Mark Truesdale active positions
Companies | Position | Start | End |
---|---|---|---|
Solentim Ltd.
Solentim Ltd. BiotechnologyHealth Technology Part of Advanced Instruments LLC, Solentim Ltd. is a British company that specializes in workflows for antibody and cell-based therapies. The company is based in Wimborne, UK. The company's technologies enable the isolation, growth, and characterization of high-value cells, while their data-driven platform enables smarter decisions earlier in the process. The CEO of the company is Mark Truesdale. Solentim was acquired by Advanced Instruments LLC on September 30, 2021 for $333.83 million. | Director/Board Member | - | - |
Chief Executive Officer | - | - |
Career history of Mark Truesdale
Statistics
International
United Kingdom | 2 |
Operational
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Solentim Ltd.
Solentim Ltd. BiotechnologyHealth Technology Part of Advanced Instruments LLC, Solentim Ltd. is a British company that specializes in workflows for antibody and cell-based therapies. The company is based in Wimborne, UK. The company's technologies enable the isolation, growth, and characterization of high-value cells, while their data-driven platform enables smarter decisions earlier in the process. The CEO of the company is Mark Truesdale. Solentim was acquired by Advanced Instruments LLC on September 30, 2021 for $333.83 million. | Health Technology |
- Stock Market
- Insiders
- Mark Truesdale
- Experience